At Mays Cancer Center at UT Health San Antonio, we are revolutionizing cancer care through breakthrough research, cutting-edge treatments and a deep commitment to saving lives. Our work doesn’t stop in the lab—we bring discoveries to the patient’s bedside, ensuring the latest advancements in cancer care are accessible to those who need them most. With a multidisciplinary team of experts, we provide best-in-class therapies, giving patients and their families hope, healing and life-changing support every step of the way.
As the only National Cancer Institute (NCI)-designated Cancer Center in South Texas, the Mays Cancer Center serves a vast 38-county region with over 5 million residents. Our team of more than 300 cancer researchers and clinicians is dedicated to transforming the way cancer is diagnosed, treated and prevented—not just in San Antonio and South Texas, but worldwide.
Our 175+ active clinical trials offer patients groundbreaking new treatment options.
Pioneering Pediatric Cancer Research
The Greehey Children’s Cancer Research Institute at UT Health San Antonio is one of only two institutes in the U.S. exclusively dedicated to pediatric cancer research. Home to more than a dozen laboratories, the institute is at the forefront of cancer genomics, DNA repair, RNA biology and drug development—all with the goal of creating safer, more effective and less toxic treatments for childhood cancers.
At UT Health San Antonio, we are more than a cancer center—we are a beacon of hope, a hub of innovation and a leader in the fight against cancer.
Join us in the fight. Together, we are making a difference!
Only National Cancer Institute-designated cancer center in South Texas
300+ cancer researchers and clinicians
World-renowned Breast Cancer Symposium
In The News
Major breakthrough could redefine drug discovery, broaden options A research team led by scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) made a major breakthrough with the potential to turn IV drugs into oral treatments for diseases like brain cancer and Alzheimer’s disease. The discovery could reshape how medicines […]
The ability of macrophages, a type of white blood cell, to transition into one of two forms, is critical for immune system functionality. These cells can morph into fighter cells (M1) that cause inflammation and attack invading pathogens, or nurse cells (M2) that soothe the inflammation and promote tissue repair after the battle. While researchers […]
Discovery of chemical endocytosis could redefine precision medicine A team of scientists, notably Zhengyu Wang, PhD, assistant professor in the department of pharmacology and the Barshop Institute, led by Hong-yu Li, PhD, professor of medicinal chemistry and chemical biology with the department of pharmacology and the Barshop Institute at The University of Texas Health Science […]